Ann-Marie Chapman
Ann-Marie joined the company in 2014, when it was known as BresMed, and has over 18 years of experience in health economics and outcomes research (HEOR) across the consultancy, pharmaceutical, and medical technology industries.
Ann-Marie has wide-ranging experience in supporting health technology assessment (HTA) submissions, new product implementation, and stakeholder engagement with appropriate value messages.